Skip to main content
Year archive

Pharming Group N.V. — 2013 filings

All 26 regulatory filings released by Pharming Group N.V. (PHARM) in 2013, sourced directly from the official regulator.

26 Filings
2013 Period
2013 filings (26)
Filing Released Lang
Interim / Quarterly Report 2013
Interim / Quarterly Report 9M 2013
2013-12-16 English
PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST (RECOMBINANT HUMAN C1 ESTERASE INHIBITOR)
Earnings Release Q3 2013
2013-11-08 English
PHARMING REPORTS ON FINANCIAL RESULTS FOR THE FIRST NINE MONTHS OF 2013
Interim / Quarterly Report 9M 2013
2013-11-07 English
PHARMING ANNOUNCES €12.0 MILLION PRIVATE EQUITY PLACEMENT WITH INSTITUTIONAL INVESTORS
Share Issue/Capital Change
2013-10-09 English
Pharming Redeems Final Tranche Of Convertible Bond For Cash
Capital/Financing Update
2013-08-30 English
PHARMING REPORTS ON FINANCIAL RESULTS FIRST HALF YEAR 2013
Interim / Quarterly Report H1 2013
2013-08-01 English
Interim / Quarterly Report 2013
Interim / Quarterly Report H1 2013
2013-08-01 English
PHARMING REDEEMS SIXTH TRANCHE OF CONVERTIBLE BOND
Capital/Financing Update
2013-07-29 English
Pharming and Shanghai Institute of Pharmaceutical Industry (SIPI) establish strategic collaboration
Regulatory Filings
2013-07-01 English
Pharming And Santarus Announce Poster Presentation Of Pivotal Clinical Data For Ruconest® (recombinant Human C1 Esterase Inhibitor)
Regulatory Filings
2013-06-25 English
Pharming Elects To Redeem Fifth Tranche Of Convertible Bond For Cash
Capital/Financing Update
2013-06-24 English
Pharming Confirms Completion Of Redemption Of Fourth Tranche Of Convertible Bond
Capital/Financing Update
2013-06-21 English
Santarus And Pharming Announce FDA Acceptance For Review Of Ruconest (Recombinant Human C1 Esterase Inhibitor) Biologics License Application
Regulatory Filings
2013-06-18 English
Pharming Announces New Data On Ruconest In Primate Model Of Delayed Graft Function (DGF)
Regulatory Filings
2013-05-23 English
Pharming confirms completion of redemption of 3rd tranche and the redemption of 4th tranche of convertible bond
Capital/Financing Update
2013-05-21 English
Interim / Quarterly Report 2013
Interim / Quarterly Report Q1 2013
2013-05-21 English
PHARMING REPORTS ON FINANCIAL RESULTS FIRST QUARTER 2013
Interim / Quarterly Report Q1 2013
2013-05-16 English
Pharming redeems third tranche of convertible bond
Share Issue/Capital Change
2013-04-17 English
Pharming and Santarus announce submission of Ruconest Biological License Application to FDA
Regulatory Filings
2013-04-17 English
Pharming confirms completion of redemption of second tranche of convertible bond
Capital/Financing Update
2013-04-12 English
Annual Report 2012
Annual Report FY 2012
2013-03-31 English
Pharming announces EMA approval of new manufacturing site for Ruconest®
Regulatory Filings
2013-03-28 English
Pharming redeems second tranche of convertible bond
Capital/Financing Update
2013-03-11 English
Pharming reports on preliminary financial results 2012
Earnings Release FY 2012
2013-03-07 English
Pharming reports on Extraordinary General Meeting
AGM Information
2013-02-28 English
Pharming announces €16.35 million convertible bond financing
Capital/Financing Update
2013-01-16 English